Response, Resistance and Metastasis of Locally Advanced Breast Cancer (LABC, Stage 2B-3C) in a Multiethnic Cohort: A Phase II International Multicentric Study of Concurrent Paclitaxel and Radiation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 27 Oct 2015 Planned End Date changed from 1 Mar 2016 to 1 Dec 2020 as reported by ClinicalTrials.gov.
- 27 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.